Tata Consultancy Services (TCS), has become India’s most valued company in terms of market capitalization, as its market capitalization has crossed USD 100 billion or Rs.6,60,000...
Cadila Healthcare has received final approval from USFDA, to market Tizanidine tablets USP in strengths of 2 mg and 4 mg. The tablets will be manufactured...
Lupin has received final approval from the US health regulator, for its Oseltamivir Phosphate. In a BSE filing the company stated that, it has received final...
The US health regulator has provided its approval to the pharma major Lupin for marketing generic version of Flagyl tablets which is used in treating...
Aurobindo Pharma has got the final approval from the USDFA for manufacturing and marketing Sevelamer Carbonate tablets in the American market. Aurobindo Pharma has said...
Lupin has got the approval from the US health regulator for marketing its Flucytosine capsules that are used in treating fungal infections. Lupin has said...
Zydus Cadila has got the tentative approval from the US health regulator for marketing anti-diabetic sitagliptin and metformin hydrochloride in the US market. Cadila Healthcare...
Zydus Cadila has got the USFDA approval for marketing tizanidine hydrochloride capsules which is a muscle relaxant, in the American market. Zydus Cadila has said...
Lupin Ltd has got a final approval from the USFDA for marketing sodium, potassium sulfate, magnesium sulfate oral solution that are used in treatment of...
Zydus Cadila‘s US subsidiary has got the approval from the US health regulator for marketing oseltamivir phosphate capsules that are used in treating Tamiflu. Cadila...